This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Cj Healthcare Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Keun Ho Lee: Innovator in Pharmaceutical Chemistry
Introduction
Keun Ho Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing critical health issues, such as constipation, through innovative solutions.
Latest Patents
One of Keun Ho Lee's notable patents is titled "Aminoalkylbenzothiazepine derivatives and uses thereof." This invention relates to a novel aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof. The patent also includes a pharmaceutical composition for preventing or treating constipation, which comprises this compound as an active ingredient. This patent highlights his commitment to advancing healthcare through innovative drug development. He holds 1 patent.
Career Highlights
Keun Ho Lee is currently associated with CJ Healthcare Corporation, a leading company in the pharmaceutical industry. His role at the company allows him to leverage his expertise in developing new therapeutic agents. His contributions have been instrumental in enhancing the company's portfolio of pharmaceutical products.
Collaborations
Throughout his career, Keun Ho Lee has collaborated with talented individuals in the field. Notable coworkers include Won-Hyuk Jung and Seung In Kim, who have worked alongside him on various projects. These collaborations have fostered a creative environment that encourages innovation and the development of groundbreaking solutions.
Conclusion
Keun Ho Lee is a dedicated inventor whose work in pharmaceutical chemistry has the potential to improve the quality of life for many individuals. His innovative approach to drug development and collaboration with skilled professionals exemplify his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile